Illinois CancerCare is a clinical research site located in Peoria, Illinois, United States 61615.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Illinois CancerCare has participated in 11 clinical trials with 4 currently active.
Therapeutic areas: Colorectal Neoplasms, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Chemotherapy-Induced Nausea and Vomiting.
Sponsors: Janssen Research & Development, LLC, Celldex Therapeutics, Helsinn Healthcare SA.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Illinois CancerCare has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Illinois CancerCare has 11 clinical trials on record, with 4 currently active. Their work covers Colorectal Neoplasms, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Chemotherapy-Induced Nausea and Vomiting.
Yes — Illinois CancerCare holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.